The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

F Share Award

4 Nov 2022 07:00

RNS Number : 2748F
Alpha FX Group PLC
04 November 2022
 

4 November 2022

Alpha FX Group plc

("Alpha FX" or the "Group")

F Share Award

Alpha FX Group plc (AIM: AFX), a high-tech, high-touch provider of FX risk management, accounts and payments solutions to corporates and institutions internationally, announces that further to the RNS on 22 June 2022 in relation to the F Shares, the Group is awarding an additional 99 F Shares. 69 F Shares are being awarded to Tim Powell following his recent appointment as CFO and Executive Director (which commences on 1 December 2022). 13 of the F Shares are being issued to Timothy Butters (who currently holds 77 E Shares), who is a PDMR of the Company, and therefore the relevant regulatory disclosure has been made in the table below. The remaining 17 F Shares are being issued to other employees. The 99 F Shares being awarded will be on the same terms as that described in the announcement of 22 June 2022.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Timothy Butters

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Risk Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Alpha FX Group plc

b)

 

LEI

 

 

213800RESM1FPUXY6K31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

F ordinary shares in Alpha FX Limited, which may be convertible into ordinary shares in Alpha FX Group plc

Identification code

ISIN: GB00BF1TM596

b)

 

Nature of the transaction

 

 

Issue of F Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

13 F Shares

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

4 November 2022

f)

 

Place of the transaction

 

 

Off market

 

 

Enquiries:

 

Alpha FX Group plc

via Alma PR

Morgan Tillbrook, Founder and CEO

Tim Kidd, CFO

Liberum Capital Limited 

(Nominated Adviser and Sole Broker) 

Tel: +44 (0) 20 3100 2000

Neil Patel

Cameron Duncan

Kate Bannatyne

Kane Collings

Alma PR (Financial Public Relations)

Tel: +44 (0) 20 3405 0205

Josh Royston

Andy Bryant

Kieran Breheny

 

Notes to Editors

Alpha is a high-tech, high-touch provider of enhanced financial solutions dedicated to corporates and institutions operating internationally. Working with clients across 50+ countries, we blend intelligent human capabilities with new technologies to solve complex problems across three key areas: FX risk management, global accounts and mass payments.

Key to our success is our team - nearly 300 people based across seven global offices, brought together by a high-performance culture and a partnership structure that empowers them to act as owners of our business.

Despite being an established business listed on the London Stock Exchange, we remain relentlessly focused on maintaining the same level of operational agility and client focus we had when we first started in 2009. This dynamic, combined with the passion of our people, have enabled us to make a substantial and enduring difference to our clients, and deliver a growth story to match.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKNBNABDDADK
Date   Source Headline
14th Dec 20215:59 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSTrading Update
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSBoard Appointment
4th Oct 20214:19 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSLaunch of next-generation banking platform
9th Sep 20212:44 pmRNSIssue of Equity
1st Sep 20217:00 amRNSInterim Report
13th Aug 202110:57 amRNSHolding(s) in Company
16th Jul 202110:29 amRNSHolding(s) in Company
14th Jul 20217:00 amRNSTrading Update
28th May 20217:00 amRNSNetherlands Office Share Ownership Scheme
27th May 20211:50 pmRNSDirector/PDMR Dealing
27th May 20217:00 amRNSTrading Update
19th May 20217:00 amRNSBoard Appointment
5th May 202110:53 amRNSResult of AGM
15th Apr 20217:00 amRNSExercise of Options
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 20217:00 amRNSNotice of AGM & Posting of Annual Report
23rd Mar 20214:16 pmRNSDirector/PDMR Dealings
17th Mar 20217:00 amRNSFull Year Results
22nd Feb 20215:56 pmRNSHolding(s) in Company
18th Feb 20212:56 pmRNSReplacement - Holding(s) in Company
12th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSTrading Update
30th Sep 20204:31 pmRNSHolding(s) in Company
16th Sep 20209:44 amRNSHolding(s) in Company
16th Sep 20209:42 amRNSHolding(s) in Company
11th Sep 20203:42 pmRNSHolding(s) in Company
11th Sep 202010:59 amRNSOption Exercise and Total Voting Rights
10th Sep 20201:30 pmRNSResult of secondary placing of Ordinary Shares
10th Sep 20207:00 amRNSProposed secondary placing of Ordinary Shares
2nd Sep 20207:00 amRNSInterim Report
13th Aug 20207:00 amRNSExercise of Options
15th Jul 20204:40 pmRNSSecond Price Monitoring Extn
15th Jul 20204:35 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSTrading Update
6th Jul 20205:12 pmRNSReplacement: Holding(s) in Company
6th Jul 20209:22 amRNSHolding(s) in Company
6th Jul 20209:20 amRNSHolding(s) in Company
24th Jun 202010:36 amRNSResult of AGM
19th Jun 20201:40 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:59 pmRNSHolding(s) in Company
1st Jun 20202:07 pmRNSNotice of Annual General Meeting
19th May 20207:00 amRNSJames Carey Appointed Director of Technology
11th May 20207:00 amRNSUpdate on Employee Share Schemes and Board Update
20th Apr 20207:00 amRNSDirectorate Change
9th Apr 20205:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.